Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Jamie Irvine

Jamie Irvine

Associate Editor, The Medicine Maker

  • Contributions

Managing Change in Devices for Patients

June 21, 2024

We need to step away from assumptions on device interchangeability and find out what patients really want

4 min read

Managing Change in Devices for Patients

Addressing the Empire of Pain

October 10, 2024

How the pharma industry can help tackle the opioid crisis and advance treatments

11 min read

Addressing the Empire of Pain

Sitting Down With… The Past: Bruno Sepodes

October 29, 2024

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

1 min read

Sitting Down With… The Past: Bruno Sepodes

Boosting Naloxone’s Effectiveness Against Opioid Overdoses

September 4, 2024

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

1 min read

Boosting Naloxone’s Effectiveness Against Opioid Overdoses

HIV: The Road to a Cure

July 15, 2024

How one company is hoping to create a functional cure for HIV

3 min read

HIV: The Road to a Cure

Pleading the CAR-T Case

July 22, 2024

Is the Risk of Secondary Cancers after CAR-T Cell Therapy Low? Stanford Researchers think so.

2 min read

Pleading the CAR-T Case

Changing Regulation Around ATMPs in Europe

May 6, 2024

Preparing for the EU’s new HTA regulation and Joint Clinical Assessment process

4 min read

Changing Regulation Around ATMPs in Europe

Top Treatment Prospects: Alzheimer’s Disease

May 20, 2024

Experts discuss the most exciting Alzheimer’s disease treatment trends – and make bold predictions for the future

9 min read

Top Treatment Prospects: Alzheimer’s Disease

Preventing Diabetes Complications

April 12, 2024

Researchers target glycocalyx to halt diabetic retinopathy and kidney disease

0 min read

Preventing Diabetes Complications

Digging into the Dangers

February 6, 2024

Research sheds new light on cancer risk in gene therapies

5 min read

Digging into the Dangers

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.